TrialDementia and geriatric cognitive disorders2010

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.

Michael Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.